- Home
- IVVD vs PHX Comparison
IVVD vs PHX Comparison
Compare IVVD & PHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- PHX
- Stock Information
- Founded
- IVVD 2020
- PHX 1926
- Country
- IVVD United States
- PHX United States
- Employees
- IVVD N/A
- PHX N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- PHX Oil & Gas Production
- Sector
- IVVD Health Care
- PHX Energy
- Exchange
- IVVD Nasdaq
- PHX Nasdaq
- Market Cap
- IVVD 116.8M
- PHX 137.2M
- IPO Year
- IVVD 2021
- PHX N/A
- Fundamental
- Price
- IVVD $0.70
- PHX $3.73
- Analyst Decision
- IVVD Strong Buy
- PHX Strong Buy
- Analyst Count
- IVVD 5
- PHX 2
- Target Price
- IVVD $7.11
- PHX $4.90
- AVG Volume (30 Days)
- IVVD 581.2K
- PHX 41.2K
- Earning Date
- IVVD 11-14-2024
- PHX 11-06-2024
- Dividend Yield
- IVVD N/A
- PHX 4.42%
- EPS Growth
- IVVD N/A
- PHX N/A
- EPS
- IVVD N/A
- PHX 0.13
- Revenue
- IVVD $11,564,000.00
- PHX $31,939,771.00
- Revenue This Year
- IVVD N/A
- PHX $5.46
- Revenue Next Year
- IVVD $72.22
- PHX $23.19
- P/E Ratio
- IVVD N/A
- PHX $28.37
- Revenue Growth
- IVVD N/A
- PHX N/A
- 52 Week Low
- IVVD $0.71
- PHX $2.95
- 52 Week High
- IVVD $5.20
- PHX $3.76
- Technical
- Relative Strength Index (RSI)
- IVVD 33.40
- PHX 60.87
- Support Level
- IVVD $0.72
- PHX $3.31
- Resistance Level
- IVVD $0.81
- PHX $3.76
- Average True Range (ATR)
- IVVD 0.07
- PHX 0.16
- MACD
- IVVD -0.02
- PHX 0.02
- Stochastic Oscillator
- IVVD 1.12
- PHX 93.48
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About PHX PHX Minerals Inc.
PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership. The company owns substantial mineral acreage, principally in Oklahoma, North Dakota, Texas, New Mexico, and Arkansas, but still maintains legacy interests in natural gas and oil properties that have retired operations. The revenues is derived from royalties granted from the production and sale of natural gas, oil and NGL, and the remaining portion of its revenues is derived from the production and sale of natural gas, oil and NGL on its working interests.